Abstract

Introduction

Materials & Methods

Results

Discussion & Conclusion

References

Discussion
Board

We recruited male subjects with mild to moderate erectile dysfunction through various medical clinics. Interested participants were enrolled at a test center located in a urology clinic at a University of Hawaii affiliated teaching hospital (Kuakini Medical Center). Subjects were enrolled in a consecutive manner until 25 patients had been enrolled for this pilot phase of the study. All interested participants were allowed to enroll regardless of etiology of erectile dysfunction. Initial work up consisted of a detailed patient past medical history including history and etiology of erectile dysfunction, treatment and medication history, and a physical examination including blood pressure, height, and weight. The subjects were then instructed on the use and regimen of ArginMax as a dietary supplement and were requested to fill out a baseline SFQ (Sexual Function Questionnaire). Subjects started a twice-per-day regimen of ArginMax, once in the morning upon waking and once in the evening at bedtime. A 4-week supply of ArginMax was provided. After completing the 4-week regimen, patients were instructed to complete a 4-week SFQ and return to the test center for follow-up evaluation and examination.

The SFQ (Sexual Function Questionnaire) was used as the primary test instrument. The SFQ is a self-administered questionnaire beginning with the validated IIEF (International Index of Erectile Function used with permission) test instrument designed to measure changes in erectile function and sexual function.(27,28,29) Following the IIEF questions, the SFQ included questions regarding subject's activities, condition during the trial period, and quality of life. (30,31)

Back to the top.